News zum Sektor Gesundheit aus Indien

 

India is urging Russia to expedite approvals for its exporters, focusing on faster registration of marine and pharmaceutical products to boost bilateral trade. Discussions also covered agricultural exports and IT services, with both nations aiming to significantly increase trade by 2030. India highlighted its global capability centers as a resource for Russian businesses....

India has urged Russia to expedite the approval of domestic establishments and registration of marine and pharmaceutical products to boost bilateral trade. During a Moscow visit, Commerce Secretary Rajesh Agrawal highlighted opportunities for expanding trade and improving market access, aiming to raise bilateral trade to $100 billion by 2030....

SEOUL (dpa-AFX) - South Korean shipbuilding company HD Hyundai Heavy Industries Co. has signed a memorandum of understanding (MOU) with Cochin Shipyard Ltd. (CSL), India's largest state-run shipbu......

India's exports to the US plummeted 37.5% between May and September 2025 due to sweeping tariff hikes by the Trump administration. Shipments fell from $8.8 billion to $5.5 billion, with smartphones and pharmaceuticals being the biggest casualties. The report highlights a sharp deterioration in India's competitiveness, risking market share loss to other nations....

Narayana Health has entered the UK market by acquiring Practice Plus Group Hospitals for Rs 2,200 crore. This strategic move expands its global presence and positions it among India's top healthcare providers. The acquisition aims to leverage Narayana Health's expertise in high-volume, accessible healthcare and technology to enhance services in the growing UK private sector....

Indian engineering and data professionals saw a significant pay drop to $22,000 in 2025, a stark contrast to the US's $150,000. While gender pay gaps persist globally, India shows near parity in tech roles, with sales achieving full gender equality. Equity-based pay is increasingly driving compensation for top talent worldwide....

Pharmazie - Roche hat in Indien einen Rückschlag in einem Patentstreit über sein SMA-Mittel Evrysdi erlitten....

Indian pharmaceutical companies are exploring opportunities to establish production facilities across Russia, with productive negotiations underway for joint ventures. This move aims to leverage India's expertise and Russia's market potential, fostering self-sufficiency in pharmaceuticals and other key sectors through complementary strengths....

Philips India is expanding its premium personal care offerings, focusing on male grooming and mother/child care to meet growing consumer demand. The company is introducing global product lines and seeing robust growth in the premium segment, indicating a shift towards value-conscious consumers. This strategy aims to accelerate growth and enhance market presence....

India and Brazil are actively discussing the expansion of their preferential trade agreement, aiming to boost market access and foster collaboration in crucial sectors like pharmaceuticals and banking. The recent Trade Monitoring Mechanism meeting focused on strengthening bilateral trade and investment, with a goal to significantly increase current trade figures. Results will be reviewed by top officials soon....

American pharmaceutical giant Eli Lilly and Company is investing over $1 billion (approx Rs 8,900 crore) in India to establish new contract manufacturing facilities, including a significant hub in Hyderabad. This strategic move aims to bolster its global manufacturing and supply capabilities, leveraging India's skilled workforce to develop and produce medicines for critical ailments....

Eli Lilly and Co. plans to invest more than $1 billion in India over the next few years to build new contract manufacturing capabilities in the South Asian nation, underscoring the US drugmaker's push to bolster its global supply network....

Eli Lilly will invest over $1 billion in India to establish new contract manufacturing facilities and a manufacturing and quality hub in Hyderabad. This significant investment aims to strengthen global supply capabilities and leverage India's skilled talent pool for producing life-changing medicines, reinforcing Hyderabad's position as a healthcare innovation hub....

Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

US President Trump announced a 100% tariff on imported branded and patented pharmaceuticals starting October 2025, aiming to boost domestic manufacturing. Indian generic drug makers are largely unaffected initially, but concerns loom over potential tariff expansion to complex generics. Sun Pharma faces significant exposure due to its US branded portfolio....

Donald Trump announced 100% tariffs on imported branded or patented pharmaceutical products from October 1, 2025, unless companies build US manufacturing facilities. This policy primarily impacts European nations exporting high-value drugs, while India's generic exports may largely be shielded, though "branded generics" classification remains a concern....

Investors of Indian pharmaceutical companies are worried about the prospect of further escalation amid U.S. trade tensions....

India is closely monitoring the potential impact of the US's proposed tariffs of up to 100% on imported branded and patented pharmaceutical drugs, set to begin October 1. The relevant ministries are examining the matter, recognizing the US as India's largest pharma export market, accounting for approximately $10 billion in FY25....

Donald Trump's tariff move impacts Indian pharma stocks. Companies like Sun Pharma, Cipla, and Dr. Reddy's face potential declines. US represents a major market for Indian exports....

Insight with Haslinda Amin, a daily news program featuring in-depth, high-profile interviews and analysis to give viewers the complete picture on the stories that matter. The show features prominent leaders spanning the worlds of business, finance, politics and culture. (Source: Bloomberg)...